Seborrheic Dermatitis Treatment Market Expected to Reach $6.6 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Seborrheic Dermatitis Treatment Market," The global seborrheic dermatitis treatment market size was valued at $2,330.1 million in 2021, and is projected to reach $6,634.2 million by 2031, registering a CAGR of 11.0% from 2022 to 2031. Seborrheic dermatitis treatment is a condition related to the skin irritation and inflammation caused due to yeast called Malassezia, stress, hormonal imbalance or over chemical usage resulting in itchy, red flakes on the scalp as well as on other parts of the body where sebaceous glands activity is the most. It is more likely seen in people with oily skin. Its symptoms are manageable with medications and does not spread with contact (non-contagious).

Seborrheic dermatitis treatment market size is driven by increase in the number of product launch and product approvals for seborrheic dermatitis treatment, increase in the awareness among the people regarding skin care, and rise in number of seborrheic dermatitis treatment industry. Moreover, rise in geriatric population is anticipated to drive the demand for seborrheic dermatitis treatment. As geriatric population is more susceptible to seborrheic dermatitis. Thus, this factor can boost the growth of seborrheic dermatitis treatment market. People in hospitals or nursing homes and those with immune-system disorders are also more prone to seborrheic dermatitis. Thus, the seborrheic dermatitis treatment market analysis include rise in the prevalence of chronic diseases such as psoriasis, AIDS and other immune system disorders which anticipated to increase in prevalence of seborrheic dermatitis.

Seborrheic dermatitis treatment is used to prevent skin infection, lowers swelling, remove flaky dandruff, and reduce itching of the scalp and other body parts as the geriatric population with low immune system are more prone to seborrheic dermatitis. Thus, rise in number of geriatric populations increases the demand for seborrheic dermatitis treatment, which drives the market growth.

Based on dosage form, the market is classified into shampoo, cream, ointment, tablet, and others. The cream segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to high presence of different anti-fungal, anti-inflammatory creams for treatment of seborrheic dermatitis and rise in adoption of over-the-counter creams for treatment of seborrheic dermatitis.

Based on treatment, it is classified into anti-inflammatory, anti-fungal, antibiotics and others. The anti-fungal segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to effectiveness of antifungal creams, lotions, gels, and shampoos for treatment of seborrheic dermatitis.

Based on type, the market is classified into prescription-based drugs and over-the-counter drugs. The prescription-based drugs segment dominated the market in 2021 and is expected to continue this trend during the seborrheic dermatitis treatment market forecast period, owing to rise in awareness among the people regarding importance of prescription-based drugs and availability of prescription-based drugs in retail and hospital pharmacy.

Based on distribution channel, the market is classified into hospital pharmacy, retail pharmacy and online pharmacy. The hospital pharmacy segment dominated the market in 2021 and is expected to continue the seborrheic dermatitis treatment market trends during the forecast period, owing to increase in the prevalence of skin disorders and rise in consultations for seborrheic dermatitis.

North America accounted for most of the global seborrheic dermatitis treatment market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to high presence of seborrheic dermatitis treatment industry and developed healthcare infrastructure. Asia-Pacific is anticipated to witness lucrative growth, owing to rise in awareness among the people regarding availability skin disease treatment and rise in adoption of high quality anti-fungal shampoos, lotions, creams, and foams.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global seborrheic dermatitis treatment market share. There is delay, reschedule, or cancellation of outpatient visits for skin disease, which hinder the market growth.

Key Findings of The Study

• By dosage form, the cream segment was the highest contributor to the market in 2021.
• By treatment, the antifungal segment was the highest contributor to the market in 2021.
• By type, the anti-fungal segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
• By distribution channel, the prescription-based drugs segment dominated the market in 2021 and is expected to continue this trend during the forecast period.
• By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.